非侵襲的血糖モニタリングデバイス市場：製品タイプ、流通チャネル、エンドユーザー、地域別、2026年～2032年

非侵襲的血糖モニタリングデバイス市場評価、2026年～2032年

非侵襲的血糖モニタリングデバイスの需要増加近年、糖尿病の有病率の増加に伴い、消費者は血糖モニタリングデバイスの利点をより認識するようになっています。パンデミックの間、糖尿病治療を含む複数の病気を治療するためのバーチャルクリニックや遠隔医療の利用が大幅に増加しました。重度の糖尿病や他の疾患を併発して入院する患者が多いため、病院セグメントが世界のグルコースモニタリングデバイス市場のエンドユーザーセグメントで最も高い割合を占めています。市場規模は2024年に3,701万米ドルを突破し、2032年には3億2,493万米ドルに達します。

非侵襲的血糖モニタリングデバイスは、患者のグルコースレベルを継続的かつ苦痛なく監視することができます。高度な機能を備えたスマートな糖尿病管理デバイスへの需要が市場を押し上げると予想されます。費用対効果が高く効率的な非侵襲的血糖モニタリングデバイスに対する需要の高まりが、2026年から2032年にかけてのCAGR 31.20%での市場の成長を可能にしています。

非侵襲的血糖モニタリングデバイス市場定義/概要

血糖モニタリングとは、血液中のグルコースレベル（血糖値）を測定するためにグルコースモニターを使用することです。糖尿病治療において特に重要な血糖値検査は、一般的に皮膚に穴を開けて（通常は指の棒で）血液を採取し、それを化学的に活性なディスポーザブルに塗布することによって行われます。

グルコースモニタリング機器は、血液中の糖レベルを検出するために不可欠なツールであり、グルコースメーター、テストストリップ、ランセットなど様々な種類があります。グルコース測定器、検査ストリップ、ランセットなど、さまざまな種類があります。これらの機器を使用することで、自宅で簡単に血糖値を測定し、治療に必要な調整を行うことができます。これにより、個人と医師は血糖値の高低を識別し、治療計画に必要な変更を加えることができます。グルコースモニタリングデバイスは、患者により大きな健康管理を提供し、急性低血糖や高血糖のリスクを軽減することで、糖尿病治療に革命をもたらしました。

非侵襲的血糖モニタリングデバイスは、糖尿病患者の血糖値を測定します。非侵襲的グルコースモニタリングは、皮膚に穴をあけることなく、消費者に痛みや外傷を与えることなく血液を測定します。血糖濃度の非侵襲的な検出は、糖尿病患者の血糖コントロールと生活の質を向上させる。さらに、1型糖尿病患者と2型糖尿病患者の両方の治療に活用されています。

糖尿病の有病率上昇は非侵襲的血糖モニタリング市場にどのような影響を与えるか？

非侵襲的血糖モニタリング市場における有病率の上昇,糖尿病は世界中でより一般的になっており、非侵襲的血糖モニタリング機器市場の成長に直接的な影響を及ぼしています。高血糖を効果的にコントロールできなければ、臓器や組織に長期的な害を及ぼす可能性があります。血糖値のモニタリングは、患者やヘルスケア専門家に過去2-3ヶ月の全体的な血糖コントロールの正確な見解を与えるため、糖尿病管理にとって重要となっています。

糖尿病の有病率の上昇は、予測される期間にわたって世界の非侵襲的血糖モニタリング機器市場の成長を促進する可能性が高いです。米国糖尿病学会（ADA）は、治療目標を達成し血糖コントロールが安定している患者には少なくとも年2回、薬が変更された患者や血糖目標を達成していない患者には四半期ごとにHbA1c値を測定することを推奨しています。

国際糖尿病連合によると、2021年には20歳から79歳のおよそ5億2,000万人が糖尿病に罹患しており、この数字は2045年までに7億人に増加すると予測されています。世界の糖尿病患者の90％以上が2型糖尿病です。

非侵襲的血糖モニタリング市場の需要を抑制する要因は何か？

最も重要な要因は、非侵襲的血糖モニター（NIBGM）の普及が拡大していることです。糖尿病患者の治療には、正確性と信頼性が不可欠です。現在のところ、NIBGM装置は旧来の方法の精度に必ずしも及ばない可能性があり、極めて正確なデータに依存しているユーザーの間で懸念が高まっています。

糖尿病患者には確立されたルーチンがあり、古い手技に慣れています。新しい技術、特に精度に問題がある可能性のある技術に切り替えるのは怖いことです。NIBGMの精度と使いやすさに信頼がおけない限り、NIBGMの導入には慎重であろう。

非侵襲的血糖測定装置は、一般的に標準的なモニターよりも高価です。このことは、特に経済的に余裕のない患者や保険適用が不十分な患者にとっては大きなハードルとなりうる。初期投資費用がかかるため、NIBGMに魅力を感じない人もいるかもしれないです。

目次

第1章 イントロダクション

• 市場の定義
• 市場セグメンテーション
• 調査手法

第2章 エグゼクティブサマリー

• 主な調査結果
• 市場概要
• 市場ハイライト

第3章 市場概要

• 市場規模と成長の可能性
• 市場動向
• 市場促進要因
• 市場抑制要因
• 市場機会
• ポーターのファイブフォース分析

第4章 非侵襲的血糖モニタリングデバイス市場：エンドユーザー別

• 病院
• 診療所
• 診断センター
• 在宅ヘルスケア

第5章 非侵襲的血糖モニタリングデバイス市場：流通チャネル別

• 小売
• 専門店
• ドラッグストア/薬局
• オンライン

第6章 非侵襲的血糖モニタリングデバイス市場：製品タイプ別

• 自己血糖測定デバイス
• グルコースストリップ
• グルコースメーター
• ランセット
• 持続血糖モニタリングデバイス

第7章 地域分析

• 北米
• 米国
• カナダ
• メキシコ
• 欧州
• 英国
• ドイツ
• フランス
• イタリア
• アジア太平洋
• 中国
• 日本
• インド
• オーストラリア
• ラテンアメリカ
• ブラジル
• アルゼンチン
• チリ
• 中東・アフリカ
• 南アフリカ
• サウジアラビア
• アラブ首長国連邦

第8章 市場力学

• 市場促進要因
• 市場抑制要因
• 市場機会
• COVID-19の市場への影響

第9章 競合情勢

• 主要企業
• 市場シェア分析

第10章 企業プロファイル

• Abbott Laboratories
• DexCom
• Tech4Life Enterprises
• Integrity Applications. Inc.
• Hoffmann-La Roche Ltd
• MediWise
• Medtronic
• Nemaura
• OrSense
• Taiwan Biophotonic Corporation

第11章 市場の展望と機会

• 新興技術
• 今後の市場動向
• 投資機会

第12章 付録

• 略語リスト
• 出典と参考文献

Non-Invasive Blood Glucose Monitoring Devices Market Valuation - 2026-2032

Rising demand for non-invasive blood glucose monitoring devices consumers have been more aware of the benefits of blood glucose monitoring devices in recent years as the prevalence of diabetes has increased. During the pandemic, there was a significant increase in the use of virtual clinics and telemedicine to treat multiple illnesses including diabetes care. The hospital segment accounted for the highest proportion of the worldwide glucose monitoring devices market's end-user segment, as many patients are admitted due to severe diabetes and other concurrent conditions. The market size surpass USD 37.01 Million valued in 2024 to reach a valuation of around USD 324.93 Million by 2032.

Non-invasive blood glucose monitoring devices provide continuous, painless surveillance of a patient's glucose levels. Demand for smart diabetes management devices with advanced features is expected to boost the market. The rising demand for cost-effective and efficient non-invasive blood glucose monitoring devices is enabling the market grow at a CAGR of 31.20% from 2026 to 2032.

Non-Invasive Blood Glucose Monitoring Devices Market: Definition/ Overview

Blood glucose monitoring is the use of a glucose monitor to determine the level of glucose in the blood (glycemia). A blood glucose test, which is especially crucial in diabetes treatment, is commonly performed by piercing the skin (usually with a fingerstick) and drawing blood, which is then applied to a chemically active disposable.

Glucose monitoring devices are an essential tool for detecting the sugar level in the blood, and they come in various types, including glucose meters, testing strips, and lancets. With the help of these devices, people can easily test their blood glucose levels at home and make necessary adjustments to their therapy. This allows individuals and their doctors to identify high or low blood glucose levels and make necessary changes to their treatment plan. Glucose monitoring devices have revolutionized diabetes care by offering patients greater control over their health and reducing the risk of acute hypoglycemia or hyperglycemia.

Non-invasive blood glucose monitoring devices measure blood glucose levels in diabetic individuals. Non-invasive glucose monitoring involves measuring blood without piercing the skin or causing pain or trauma to the consumer, which is why non-invasive gadgets are so popular. Non-invasive detection of blood glucose concentration improves blood sugar control and the quality of life for diabetics. Furthermore, it is utilized to treat both Type 1 and Type 2 diabetic patients.

How will Rising Prevalence of Diabetes Affect Non-Invasive Blood Glucose Monitoring Market?

Rising Prevalence in non-invasive blood glucose monitoring market, Diabetes has grown more common around the world, which has a direct impact on the growth of the non-invasive blood glucose monitoring equipment market. If high blood sugar is not effectively controlled it can cause long-term harm to organs and tissues. Monitoring blood sugar levels has become critical for diabetes management since it gives patients and healthcare professionals an accurate view of overall blood sugar control over the previous 2-3 months.

The rising prevalence of diabetes is likely to drive the growth of the global non-invasive blood glucose monitoring devices market over the predicted period. The American Diabetes Association (ADA) recommends measuring HbA1c levels at least twice a year for patients who are meeting treatment objectives and have stable glycemic control, and quarterly for patients whose medication has changed or who are not meeting glycemic goals.

According to the International Diabetes Federation, roughly 520 million persons aged 20 to 79 had diabetes in 2021, and this figure is anticipated to climb to 700 million by 2045. Type 2 diabetes accounts for more than 90% of diabetes cases worldwide.

What are the Factors Restraining Demand for Non-Invasive Blood Glucose Monitoring Market?

The most significant factor is are expanding prevalence of non-invasive blood glucose monitor (NIBGM), it is a very new technology as compared to older finger-prick procedures. Accuracy and dependability are critical for diabetics in treating their condition. Currently, NIBGM devices may not always equal the precision of older methods, raising concerns among users who rely on extremely accurate data.

People with diabetes have established routines and are familiar with older procedures. Switching to a new technology, particularly one with potential accuracy issues can be scary. They may be cautious to adopt NIBGM unless they have trust in its accuracy and usability.

Non-Invasive blood glucose monitoring devices are typically more expensive than standard monitors. This can be a substantial hurdle for patients especially those with little financial resources or insufficient insurance coverage. The initial investment expense may make NIBGM less appealing for some.

Category-Wise Acumens

How the Segment Self-Monitoring Device will Dominate the Non-Invasive Blood Glucose Monitoring Devices Market?

The self-monitoring devices segment is substantially leading the non-invasive blood glucose monitoring devices market owing to the catering to individuals with diabetes who require regular monitoring of their blood sugar levels. This market includes a variety of self-testing products, such as glucose strips, glucose meters, and lancets. These devices enable diabetics to easily and accurately monitor their glucose levels at home, allowing them to make educated decisions regarding their diabetes treatment routine.

Glucose meters are booming the non-invasive blood glucose monitoring devices market, glucose meters are handheld electronic devices used to measure and display blood glucose levels based on the readings obtained from glucose strips. These meters play a critical role in self-monitoring blood glucose devices, providing users with real-time feedback on their glucose levels. The glucose meter segment is characterized by ongoing technological advancements aimed at improving accuracy, speed, and user-friendliness. Key features such as wireless connectivity, data storage, and compatibility with mobile apps are increasingly incorporated into glucose meters to enhance usability and convenience for individuals managing diabetes.

How will the Home Healthcare and Hospitals Segment Control the Non-Invasive Blood Glucose Monitoring Devices Market?

The home healthcare segment dominates the market for non-invasive blood glucose monitoring devices, the hospital segment is seeing significant growth opportunities due to increased adoption of advanced monitoring technologies and a growing emphasis on improving diabetes management in healthcare facilities.

Due to a number of factors, including an increase in the global prevalence of diabetes, a greater emphasis on patient-centered care, and a growing desire for convenient and accessible monitoring systems. Individuals with diabetes prefer the convenience and privacy of monitoring their blood glucose levels at home rather than frequent visits to healthcare institutions. Non-invasive blood glucose monitoring devices designed for home usage provide ease of use, portability, and real-time data tracking, empowering patients to efficiently manage their condition between healthcare consultations.

While the home healthcare segment leads the industry, the hospital segment is rapidly expanding and deemed thriving. Hospitals continue to be significant end users of non-invasive blood glucose monitoring devices, particularly for diabetes management in hospitalized patients and those requiring intensive care.

Country/Region-wise Acumens

How Does North America Emerge the Non-Invasive Blood Glucose Monitoring Devices Market?

North America emerges as the leading force in the projected market for non-invasive blood glucose monitoring devices, in 2019, North America led the global market for non-invasive blood glucose monitoring devices by revenue, followed by Europe. The region's huge market share can be due to its high disease prevalence and well-established healthcare infrastructure, which allows for accurate diagnosis. In 2018, the American Diabetes Association reported that 34.2 million people in the United States had diabetes, accounting for 10.5% of the population. Type 1 diabetes affects 1.6 million people, including around 187,000 children and adolescents.

North America's dominance in the predicted market for non-invasive blood glucose monitoring devices is due to excellent reimbursement policies, greater diabetes awareness, well-developed healthcare infrastructure, and a supportive regulatory environment. As these factors continue to drive demand and acceptance, North America is expected to maintain its dominance in the global market for non-invasive blood glucose monitoring devices.

Will Non-Invasive Blood Glucose Monitoring Devices Market Witness Rapid Growth in Asia Pacific?

The Asia Pacific market is poised to grow rapidly during the projected period, driven primarily by the rising prevalence of diabetes and increased knowledge about its diagnosis and treatment. This increase in diabetes prevalence is especially noticeable in Asia Pacific, where the majority of countries are experiencing rapid economic growth. As a result, many healthcare companies are making significant investments in the region to capitalize on the growing demand for non-invasive blood glucose monitoring devices and related technology. These collaborative efforts are critical in driving the market's growth throughout Asia Pacific.

According to data from the International Diabetes Federation (IDF), the prevalence of diabetes is increasing in developing nations, owing to rapid and ongoing socioeconomic changes. This trend is projected to continue, driving up demand for non-invasive blood glucose monitoring devices in Asia Pacific.

As the region's economies mature and healthcare infrastructure improves, there is an increasing need to treat the rising diabetes burden. As a result, the combination of rising illness prevalence, increased awareness, and significant investments highlights the non-invasive blood glucose monitoring devices market's enormous growth potential in Asia Pacific.

Competitive Landscape

The non-invasive blood glucose monitoring devices market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the non-invasive blood glucose monitoring devices market include:

• DiaMonTech GmbH
• Nemaura Medical, Inc.
• Integrity Applications, Inc.
• CNOGA Medical Ltd.
• Breath Health, Inc.
• Metamaterial Technologies, Inc.
• Opticology, Inc.
• NovioSense BV
• Quick LLC
• RSP Systems A/S
• Abbott (U.S.)
• GlySens Incorporated
• Novo Nordisk
• PHC Holdings Corporation
• TaiDoc Technology Corporation
• AgaMatrix
• Dexcom, Inc.

Latest Developments

• In May 2024, Abbott announced new programs aimed at increasing diversity in medical trials and improving care for underrepresented communities.
• In June 2024, Know Labs, a medical diagnostic business, plans to launch the first commercially available non-invasive glucose monitor, the Generation 1 gadget.

In May 2019, Nemaura got a CE mark for SugarBEAT, a non-invasive continuous glucose monitoring device, for sale in EU territories.Non-Invasive Blood Glucose Monitoring Devices Market, By Category

• Product Type:
• Self-Monitoring Blood Glucose Devices
• Glucose strips
• Glucose meter
• Lancets
• Continuous Glucose Monitoring Devices
• Distribution Channel:
• Retail
• Specialty Stores
• Drug Stores/Pharmacies
• Online
• End-User:
• Hospital
• Clinics
• Diagnostic Centers
• Home Healthcare
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Non-Invasive Blood Glucose Monitoring Devices Market, By End-User:

• Hospital
• Clinics
• Diagnostic Centers
• Home Healthcare

5. Non-Invasive Blood Glucose Monitoring Devices Market, By Distribution Channel:

• Retail
• Specialty Stores
• Drug Stores/Pharmacies
• Online

6. Non-Invasive Blood Glucose Monitoring Devices Market, By Product Type

• Self-Monitoring Blood Glucose Devices
• Glucose strips
• Glucose meter
• Lancets
• Continuous Glucose Monitoring Devices

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Abbott Laboratories
• DexCom
• Tech4Life Enterprises
• Integrity Applications. Inc.
• Hoffmann-La Roche Ltd
• MediWise
• Medtronic
• Nemaura
• OrSense
• Taiwan Biophotonic Corporation

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References